
X
BI drug named Promising Innovative Medicine in mesothelioma
https://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/
Immunocore has gained a Promising Innovative Medicines (PIM) designation in the UK for its candidate immunotherapy for patients with metastatic uveal melanoma, a rare tumour of the eye.
A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy.